Introduction
Clinical trials represent the most rigorous approach to evaluating the efficacy of interventions. The clinical trial is a relatively young methodology, used rarely until the middle of the twentieth century. Most clinical trials evaluate medications. In fact a review of clinicaltrials. gov in 2011 indicated that of more than 100,000 registered trials, over 70% were drug trials [1] . The remainder was divided among devices, surgery, and behavioral and educational interventions. While drug trials are important for development of therapeutics in osteoarthritis, trials of surgery, devices, and educational and behavioral interventions are critical as well.
Typical Clinical Trial Methodologies
Most of the methodology for clinical trials was developed for evaluation of medications. Other types of interventions pose unique challenges to the clinical trial paradigm. Table 1 lists five methodological considerations (standardization, concealment, contamination, equipoise, and crossover) and summarizes the extent that these methods may pose concerns for trials evaluating drugs, devices or surgery, or behavioral trials.
Standardization It is axiomatic that scientific studies must be standardized and reproducible. Drugs are particularly suitable to standardization in appearance, composition, and dose. Standardization of surgical techniques is more difficult, as each case is unique. Standardization of behavioral or educational interventions is similarly challenging because interventions are necessarily customized to the patient's impairments and style. For such trials of tailored interventions, it is especially important to develop detailed protocols that specify a standard intervention strategy, even if elements of the strategy are individualized. Site visits, simulated exercises, and review of video or audiotapes of interventions can also enhance standardization.
Concealment or blinding of the intervention is relatively simple to accomplish in drug trials with placebos. In surgical trials, blinding of patients and observers is much more difficult unless the design includes a sham surgery. Sham-controlled surgical trials raise ethical and numerous logistical concerns. Despite their potential scientific value [3] , sham surgical trials are seldom performed. Behavioral studies cannot truly blind the provider or patient, making it important to include attention control for the potential benefits of ongoing human contact.
Contamination is a concern in interventions given at the group level. For example, in a trial of injury prevention, if different players on the same team were randomized to different groups (active intervention vs. control), team members in the intervention group could share intervention techniques with teammates in the control group. Randomization at the group level, or cluster randomization, overcomes this limitation. However, in cluster randomized trials, the individual observations are not independent. Consequently, the effective sample size is smaller than the actual sample size, and trials need to enroll more patients than would be predicted based upon standard calculations.
Equipoise is a state of comfort with any of the treatment options under study. Investigators must experience equipoise to refer patients into randomized clinical trials, and patients must experience equipoise to decide to enroll. If the clinician has a strong intuition that a patient who is eligible for the trial would benefit from surgery, is it ethical to recommend randomization? Similarly, if the clinician feels that an eligible patient is not likely to benefit from surgery, is it ethical to randomize? Is uncertainty (lack of preference) required to justify randomization? Most ethicists feel what is required is that the patient makes a noncoerced choice. If patients who are eligible for the trial are not referred for enrollment because the physician is uncomfortable randomizing, selection bias can occur, threatening the validity of the findings [2] . This is particularly pertinent to surgical trials, as surgeons are especially vulnerable to discomfort referring a patient who came to the surgeon's office seeking definitive advice for treatment to a trial in which treatment is defined by chance.
Crossovers are especially likely in surgical trials [4] . Subjects randomized to receive nonoperative therapy may be impatient with the results and ask for surgery. Patients randomized to surgery may decide not to go through with the operation. This problem threatens the validity of findings from a randomized clinical trial. The appropriate approach to analysis is intention to treat (ITT), in which subjects are analyzed in the group to which they were assigned, irrespective of the treatment they received. In the face of crossover, the trial results will resemble those shown in Fig. 1 . Patients are randomized to the yellow and blue groups. But if some of the yellow group received the blue intervention and vice versa, the final comparison groups in the ITT analysis will be a hybrid of yellow and blue interventions, making the results difficult to interpret and making a null effect more likely.
Conclusions
Clinical trials provide the most rigorous methodology for evaluating interventions. Indeed, there is wide agreement that the field needs more trials to bolster the evidence base for treatment of OA. OA interventions include medications, devices, surgical procedures, and behavioral programs among others. Each of these intervention types poses its own set of methodologic challenges. Five particularly important considerations in the design and implementation of trials are standardization, concealment, contamination, equipoise, and crossover. Investigators embarking on trials of OA interventions should be attuned to these issues and should review prior trials carefully and speak with other investigators to develop approaches to maintaining methodologic rigor despite these threats to validity. 
